Baxter International Inc

Thêm thông tin về Baxter International Inc Công ty

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Thông tin công ty

Mã công tyBAX

Tên công tyBaxter International Inc

Ngày IPOMay 15, 1961

Được thành lập vào1931

CEOMr. D. Brent Shafer

Số lượng nhân viên38000

Loại chứng khoánOrdinary Share

Kết thúc năm tài chínhMay 15

Địa chỉOne Baxter Parkway

Thành phốDEERFIELD

Sàn giao dịch chứng khoánNYSE Consolidated

Quốc giaUnited States of America

Mã bưu điện60015

Điện thoại12249482000

Trang webhttps://www.baxter.com/

Mã công tyBAX

Ngày IPOMay 15, 1961

Được thành lập vào1931

Lãnh đạo công ty

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

118.15K

+10.70%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

28.52K

+2.77%

Ms. Catherine R. (Cathy) Smith

Independent Director

23.05K

+2.74%

Ms. Patricia B. Morrison

Independent Director

15.76K

-25.89%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

9.27K

+2.46%

Mr. Jeffrey A. (Jay) Craig

Independent Director

3.47K

--

Ms. Nancy M. Schlichting

Lead Independent Director

787.00

-88.29%

Xem thêm

Tên

Tên/Chức vụ

Chức vụ

Tỷ lệ sở hữu cổ phần

Thay đổi

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

118.15K

+10.70%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

28.52K

+2.77%

Ms. Catherine R. (Cathy) Smith

Independent Director

23.05K

+2.74%

Phân tích doanh thu

Tiền tệ: USDThời gian cập nhật: CN, 6 Th04

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

Theo Khu vựcUSD

Tên

Doanh thu

Tỷ trọng

United States

5.85B

55.00%

International

4.79B

45.00%

Theo Doanh nghiệp

Theo Khu vực

Theo Doanh nghiệpUSD

Tên

Doanh thu

Tỷ trọng

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

Cổ đông

Thời gian cập nhật: 18 giờ trước

Cổ đông Thống kê

Loại

Cổ đông Thống kê

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

11.80%

Dodge & Cox

10.06%

Pzena Investment Management, LLC

6.56%

BlackRock Institutional Trust Company, N.A.

5.76%

State Street Global Advisors (US)

4.25%

Other

61.58%

Cổ đông Thống kê

Cổ đông

Tỷ trọng

The Vanguard Group, Inc.

11.80%

Dodge & Cox

10.06%

Pzena Investment Management, LLC

6.56%

BlackRock Institutional Trust Company, N.A.

5.76%

State Street Global Advisors (US)

4.25%

Other

61.58%

Loại

Cổ đông

Tỷ trọng

Investment Advisor/Hedge Fund

53.40%

Investment Advisor

32.35%

Research Firm

2.70%

Hedge Fund

2.37%

Pension Fund

2.23%

Insurance Company

1.44%

Bank and Trust

1.13%

Sovereign Wealth Fund

1.00%

Individual Investor

0.36%

Other

3.01%

Cổ phần của tổ chức

Thời gian cập nhật: T5, 20 Th02

Chu kỳ Báo cáo

Số lượng tổ chức

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

2025Q1

1902

499.25M

97.33%

-40.58M

2024Q4

1984

501.11M

97.98%

-41.68M

2024Q3

2005

485.40M

95.14%

-42.32M

2024Q2

2042

472.72M

92.77%

-47.98M

2024Q1

2091

469.13M

92.11%

-57.76M

2023Q4

2137

471.69M

92.98%

-44.04M

2023Q3

2123

465.39M

91.91%

-35.52M

2023Q2

2140

458.55M

90.66%

-30.65M

2023Q1

2123

459.27M

90.86%

-22.24M

2022Q4

2132

456.58M

90.57%

-21.28M

Xem thêm

Hoạt động của Cổ đông

Tên

Cổ phiếu nắm giữ

Tỷ trọng

Thay đổi

Thay đổi %

Ngày

The Vanguard Group, Inc.

60.53M

11.8%

+468.84K

+0.78%

Dec 31, 2024

Dodge & Cox

51.58M

10.06%

+1.20M

+2.39%

Feb 28, 2025

Pzena Investment Management, LLC

33.64M

6.56%

+1.42M

+4.39%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

29.53M

5.76%

-652.43K

-2.16%

Dec 31, 2024

State Street Global Advisors (US)

21.79M

4.25%

+12.21K

+0.06%

Dec 31, 2024

BlackRock Financial Management, Inc.

17.57M

3.43%

+1.23M

+7.54%

Dec 31, 2024

T. Rowe Price Associates, Inc.

15.25M

2.97%

+1.13M

+8.03%

Dec 31, 2024

Geode Capital Management, L.L.C.

12.45M

2.43%

+290.28K

+2.39%

Dec 31, 2024

Harris Associates L.P.

8.46M

1.65%

-1.31M

-13.43%

Dec 31, 2024

Columbia Threadneedle Investments (US)

7.28M

1.42%

-2.29M

-23.93%

Dec 31, 2024

Xem thêm

ETF liên quan

Thời gian cập nhật: CN, 6 Th04

Tên

Tỷ trọng

Parnassus Value Select ETF

5.07%

Cullen Enhanced Equity Income ETF

3.53%

iShares Large Cap Value Active ETF

2.45%

Global X S&P 500 Quality Dividend ETF

2%

iShares U.S. Medical Devices ETF

1.92%

Invesco S&P 500 Equal Weight Health Care ETF

1.76%

SPDR S&P Health Care Equipment ETF

1.52%

First Trust Indxx Medical Devices ETF

1.27%

ROBO Global Healthcare Technology & Innovation ETF

0.98%

Humankind US Stock ETF

0.85%

Xem thêm

Parnassus Value Select ETF

Tỷ trọng5.07%

Cullen Enhanced Equity Income ETF

Tỷ trọng3.53%

iShares Large Cap Value Active ETF

Tỷ trọng2.45%

Global X S&P 500 Quality Dividend ETF

Tỷ trọng2%

iShares U.S. Medical Devices ETF

Tỷ trọng1.92%

Invesco S&P 500 Equal Weight Health Care ETF

Tỷ trọng1.76%

SPDR S&P Health Care Equipment ETF

Tỷ trọng1.52%

First Trust Indxx Medical Devices ETF

Tỷ trọng1.27%

ROBO Global Healthcare Technology & Innovation ETF

Tỷ trọng0.98%

Humankind US Stock ETF

Tỷ trọng0.85%

Cổ tức

Tổng cộng 2.75B USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Ngày

Cổ tức

Ngày ghi sổ

Ngày thanh toán

Ngày không hưởng cổ tức

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Nov 14, 2023

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 18, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

May 01, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023

Jun 02, 2023

Jul 03, 2023

Jun 01, 2023

Feb 14, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option

Feb 24, 2023

Apr 03, 2023

Feb 23, 2023

Nov 15, 2022

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022

Dec 02, 2022

Jan 03, 2023

Dec 01, 2022

Xem thêm

Chia tách cổ phiếu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

Ngày

Loại

Tỷ lệ

Không có dữ liệu

31.140USD

Baxter International Inc

31.140

Tổng quan

Công ty